Company: BKYI
Filing Date: 2025-04-25
Form Type: S-1
Source: 0001437749-25-013165
Chunk: 9

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-04-25
Form: S-1
Chunk 9
---
 Market under the ticker symbol “BKYI”.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Risk factors:                                                                                                                                                       | Investing in our securities involves a high degree of risk and purchasers of our securities may lose their entire investment. See the information under the caption “Risk Factors” beginning on page 5 of this prospectus and the other information included elsewhere in this prospectus and incorporated by reference herein for a discussion of factors you should consider before deciding to invest in our securities.                                                                                                                                                                                      |

<div align='center'>4</div>

The number of shares of our common stock to be outstanding after this offering is based on 5,814,041 shares of our common stock outstanding as of April 23, 2025, plus an aggregate of 3,091,668 shares of common stock issuable upon exercise of Series A warrants and Series B warrants, and excludes as of such date:

| ● | 3,007 shares of common stock issuable upon the exercise of stock options, with a weighted-average exercise price of $197.31 per share;           |
| ● | 2,739,362 shares of common stock issuable upon the exercise of outstanding warrants, with a weighted-average exercise price of $11.12 per share; |
| ● | 421,905 shares of common stock issuable on exercise of warrants with an exercise price of $3.15 per share;                                       |
| ● | 31,131 shares of common stock issuable upon exercise of pre-funded warrants with an exercise price of $0.018 per share;                          |
| ● | 529 shares of common stock reserved for future issuance under our 2015 Equity Incentive Plan;                                                    |
| ● | 35,050 shares of common stock reserved for future issuance under our 2021 Employee Stock Purchase Plan;                                          |
| ● | 155,957 shares of common stock reserved for future issuance under our 2023 Stock Incentive Plan.                                                 |

<div align='center'>RISK FACTORS</div>

Investing in our securities involves a high degree of risk. Before deciding to invest in our securities, you should consider carefully the risks and uncertainties described below and under Item 1A.“Risk Factors”in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission, or SEC, on April 23, 2025, which are incorporated by reference in this prospectus, together with all of the other information contained in this prospectus